Phosphodiesterase 4 Inhibitor [EPC]

Phosphodiesterase 4 Inhibitor [EPC] was reported 163127 times

These side effects are most commonly reported by patients taking drugs of the Phosphodiesterase 4 Inhibitor [EPC] class:

# Drug class Count
0 DIARRHOEA 25491
1 NAUSEA 22866
2 PSORIASIS 20775
3 HEADACHE 18572
4 DRUG INEFFECTIVE 18232
5 ABDOMINAL DISCOMFORT 8477
6 PSORIATIC ARTHROPATHY 8345
7 PAIN 7772
8 RASH 7683
9 VOMITING 6833
10 ARTHRALGIA 6770
11 FATIGUE 6744
12 OFF LABEL USE 6645
13 DEPRESSION 5866
14 WEIGHT DECREASED 5588
15 PRURITUS 5296
16 PRODUCT DOSE OMISSION ISSUE 5278
17 MALAISE 5096
18 ABDOMINAL PAIN UPPER 5083
19 CONDITION AGGRAVATED 4879
20 PRODUCT DOSE OMISSION 4644
21 DECREASED APPETITE 4279
22 DYSPNOEA 3989
23 DIZZINESS 3956
24 THERAPY NON-RESPONDER 3955
25 INSOMNIA 3838
26 NASOPHARYNGITIS 3615
27 JOINT SWELLING 3519
28 RHEUMATOID ARTHRITIS 3462
29 ALOPECIA 3449
30 HYPERTENSION 3428
31 ADVERSE DRUG REACTION 3414
32 PAIN IN EXTREMITY 3277
33 HYPERSENSITIVITY 3272
34 PNEUMONIA 3255
35 DRUG INTOLERANCE 3187
36 INFECTION 3163
37 GASTROINTESTINAL DISORDER 3125
38 ARTHROPATHY 3080
39 SYNOVITIS 3071
40 GENERAL PHYSICAL HEALTH DETERIORATION 3015
41 PERIPHERAL SWELLING 2984
42 MUSCULOSKELETAL STIFFNESS 2945
43 DRUG HYPERSENSITIVITY 2941
44 HYPOAESTHESIA 2896
45 TREATMENT FAILURE 2816
46 SWELLING 2762
47 THERAPEUTIC PRODUCT EFFECT DECREASED 2742
48 URTICARIA 2741
49 INFUSION RELATED REACTION 2739
50 HEPATIC ENZYME INCREASED 2737
51 MOBILITY DECREASED 2695
52 SYSTEMIC LUPUS ERYTHEMATOSUS 2688
53 SINUSITIS 2659
54 WOUND 2634
55 DRUG DOSE OMISSION 2619
56 MIGRAINE 2614
57 DYSPEPSIA 2596
58 DISCOMFORT 2594
59 ASTHENIA 2588
60 GLOSSODYNIA 2580
61 TYPE 2 DIABETES MELLITUS 2545
62 HAND DEFORMITY 2511
63 WEIGHT INCREASED 2485
64 DEATH 2452
65 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2435
66 MUSCLE SPASMS 2418
67 ANXIETY 2388
68 BLISTER 2351
69 BLOOD CHOLESTEROL INCREASED 2343
70 FIBROMYALGIA 2335
71 PERICARDITIS 2325
72 MEMORY IMPAIRMENT 2316
73 WHEEZING 2300
74 PEMPHIGUS 2284
75 PYREXIA 2272
76 PRODUCT USE IN UNAPPROVED INDICATION 2255
77 DUODENAL ULCER PERFORATION 2235
78 RHEUMATIC FEVER 2214
79 HELICOBACTER INFECTION 2196
80 SLEEP DISORDER 2172
81 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2160
82 FOLLICULITIS 2159
83 IRRITABLE BOWEL SYNDROME 2154
84 INJURY 2126
85 CONFUSIONAL STATE 2113
86 PRODUCT USE ISSUE 2098
87 STOMATITIS 2076
88 IMPAIRED HEALING 2073
89 INFLAMMATION 2008
90 ABDOMINAL PAIN 1998
91 COUGH 1988
92 MATERNAL EXPOSURE DURING PREGNANCY 1957
93 OSTEOARTHRITIS 1924
94 BACK PAIN 1871
95 CONTRAINDICATED PRODUCT ADMINISTERED 1862
96 DRY MOUTH 1818
97 LIVER INJURY 1800
98 RHEUMATOID FACTOR POSITIVE 1793
99 C-REACTIVE PROTEIN INCREASED 1786
100 CHEST PAIN 1756
101 JOINT RANGE OF MOTION DECREASED 1729
102 UPPER RESPIRATORY TRACT INFECTION 1717
103 ASTHMA 1693
104 ILL-DEFINED DISORDER 1678
105 GASTROOESOPHAGEAL REFLUX DISEASE 1672
106 MUSCLE INJURY 1654
107 LOWER RESPIRATORY TRACT INFECTION 1641
108 ARTHRITIS 1637
109 GAIT INABILITY 1636
110 INTENTIONAL PRODUCT USE ISSUE 1619
111 C-REACTIVE PROTEIN ABNORMAL 1611
112 CONTUSION 1609
113 SWOLLEN JOINT COUNT INCREASED 1574
114 GAIT DISTURBANCE 1539
115 ADVERSE EVENT 1516
116 FALL 1512
117 BURSITIS 1500
118 LUNG DISORDER 1456
119 WOUND INFECTION 1455
120 PARAESTHESIA 1451
121 FACET JOINT SYNDROME 1446
122 APPLICATION SITE PAIN 1441
123 HYPERCHOLESTEROLAEMIA 1440
124 MUSCULAR WEAKNESS 1376
125 ROAD TRAFFIC ACCIDENT 1375
126 GASTRIC DISORDER 1366
127 FEELING ABNORMAL 1364
128 THERAPEUTIC RESPONSE DECREASED 1346
129 LIP DRY 1345
130 SCIATICA 1343
131 ERYTHEMA 1342
132 MUSCULOSKELETAL PAIN 1342
133 BURNING SENSATION 1332
134 GRIP STRENGTH DECREASED 1326
135 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1318
136 OEDEMA 1301
137 NIGHT SWEATS 1290
138 COVID-19 1263
139 FREQUENT BOWEL MOVEMENTS 1263
140 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1197
141 BRONCHITIS 1145
142 ABDOMINAL DISTENSION 1144
143 LIVER DISORDER 1133
144 BREAST CANCER STAGE III 1131
145 INFLUENZA 1124
146 LOWER LIMB FRACTURE 1122
147 THERAPY INTERRUPTED 1101
148 OBESITY 1067
149 STRESS 1064
150 PERIPHERAL VENOUS DISEASE 1062
151 AUTOIMMUNE DISORDER 1046
152 JOINT STIFFNESS 1036
153 OEDEMA PERIPHERAL 1021
154 EXPOSURE DURING PREGNANCY 1014
155 DEEP VEIN THROMBOSIS POSTOPERATIVE 1005
156 UNEVALUABLE EVENT 1005
157 VISUAL IMPAIRMENT 981
158 INTENTIONAL PRODUCT MISUSE 955
159 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 953
160 PULMONARY FIBROSIS 938
161 AMNESIA 936
162 NECK PAIN 936
163 DRY SKIN 914
164 LIVER FUNCTION TEST INCREASED 908
165 RED BLOOD CELL SEDIMENTATION RATE INCREASED 908
166 TREMOR 896
167 LIVE BIRTH 889
168 DRUG-INDUCED LIVER INJURY 882
169 OSTEOPOROSIS 880
170 BONE EROSION 876
171 PRESCRIBED OVERDOSE 876
172 HEPATIC CIRRHOSIS 872
173 URINARY TRACT INFECTION 868
174 EXOSTOSIS 856
175 BLEPHAROSPASM 850
176 EAR INFECTION 838
177 SKIN EXFOLIATION 836
178 DISLOCATION OF VERTEBRA 819
179 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 811
180 DELIRIUM 811
181 EPILEPSY 809
182 TASTE DISORDER 809
183 SUICIDAL IDEATION 801
184 PRODUCT QUALITY ISSUE 793
185 MYALGIA 788
186 KNEE ARTHROPLASTY 781
187 DRUG EFFECT DECREASED 774
188 HIP ARTHROPLASTY 773
189 JOINT DISLOCATION 768
190 NAIL DISORDER 768
191 ILLNESS 755
192 HOSPITALISATION 738
193 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 737
194 CONSTIPATION 724
195 ECZEMA 720
196 PRESCRIBED UNDERDOSE 718
197 FOOT DEFORMITY 714
198 LARYNGITIS 703
199 BLOOD PRESSURE INCREASED 699
200 CROHN^S DISEASE 698
201 RASH PRURITIC 698
202 ONYCHOMADESIS 697
203 BACK INJURY 685
204 FLATULENCE 683
205 INCORRECT DOSE ADMINISTERED 679
206 RHINORRHOEA 658
207 LUPUS VULGARIS 643
208 RETINITIS 643
209 PALPITATIONS 638
210 LUPUS-LIKE SYNDROME 631
211 DERMATITIS ATOPIC 630
212 X-RAY ABNORMAL 613
213 RESPIRATORY DISORDER 600
214 NASAL CONGESTION 592
215 SKIN DISORDER 592
216 ADVERSE REACTION 591
217 TACHYCARDIA 551
218 SKIN BURNING SENSATION 548
219 THERAPY CESSATION 544
220 INJECTION SITE REACTION 537
221 HEART RATE INCREASED 527
222 OROPHARYNGEAL PAIN 523
223 PREGNANCY 517
224 C-REACTIVE PROTEIN 509
225 DISABILITY 509
226 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 497
227 ONYCHOMYCOSIS 495
228 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 493
229 DEPRESSED MOOD 492
230 NEOPLASM MALIGNANT 484
231 INFLUENZA LIKE ILLNESS 465
232 BREAST CANCER STAGE II 462
233 CHEST DISCOMFORT 460
234 SOMNOLENCE 452
235 UNDERDOSE 447
236 DRUG EFFECT INCOMPLETE 446
237 HERPES ZOSTER 445
238 MYOCARDIAL INFARCTION 444
239 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 437
240 DEHYDRATION 437
241 HYPERHIDROSIS 436
242 INJECTION SITE PAIN 436
243 WALKING AID USER 436
244 CELLULITIS 433
245 PRODUCTIVE COUGH 429
246 MOOD ALTERED 426
247 FEELING HOT 424
248 CARDIAC DISORDER 423
249 CEREBROVASCULAR ACCIDENT 421
250 COELIAC DISEASE 416
251 EAR PAIN 416
252 SKIN DISCOLOURATION 413
253 MEDICATION ERROR 411
254 NEPHROLITHIASIS 397
255 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 394
256 HEPATITIS 385
257 OVERDOSE 383
258 RESPIRATORY TRACT INFECTION 382
259 BACK DISORDER 376
260 ATRIAL FIBRILLATION 374
261 FINGER DEFORMITY 372
262 PANCREATITIS 372
263 TENSION HEADACHE 368
264 CHILLS 364
265 ENTHESOPATHY 360
266 SURGERY 358
267 SKIN FISSURES 357
268 RASH MACULAR 353
269 DIABETES MELLITUS 348
270 PRODUCT LABEL CONFUSION 347
271 BLOOD GLUCOSE INCREASED 345
272 SKIN IRRITATION 343
273 IRRITABILITY 337
274 TENOSYNOVITIS 336
275 PRODUCT ADMINISTRATION INTERRUPTED 331
276 RECTAL HAEMORRHAGE 331
277 TENDONITIS 318
278 FAECES SOFT 317
279 FLUID RETENTION 314
280 DRUG TOLERANCE DECREASED 312
281 SERONEGATIVE ARTHRITIS 309
282 PUSTULAR PSORIASIS 308
283 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 299
284 ALANINE AMINOTRANSFERASE INCREASED 295
285 MOOD SWINGS 294
286 SKIN ULCER 289
287 COLITIS ULCERATIVE 288
288 PRODUCT SUPPLY ISSUE 285
289 ASPARTATE AMINOTRANSFERASE INCREASED 284
290 NERVOUSNESS 280
291 SKIN LESION 280
292 RASH ERYTHEMATOUS 279
293 RENAL FAILURE 273
294 WHITE BLOOD CELL COUNT INCREASED 273
295 HYPOTENSION 272
296 VISION BLURRED 272
297 SEPSIS 271
298 ANAEMIA 270
299 RENAL IMPAIRMENT 269
300 CATARACT 266
301 NO ADVERSE EVENT 264
302 LOSS OF CONSCIOUSNESS 260
303 SKIN HAEMORRHAGE 260
304 DIVERTICULITIS 254
305 BREAST CANCER 253
306 DYSGEUSIA 253
307 INFUSION SITE REACTION 253
308 APPLICATION SITE ERYTHEMA 251
309 TONGUE DISORDER 251
310 HAEMATOCHEZIA 246
311 SINUS DISORDER 246
312 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 245
313 ULCER 245
314 SWELLING FACE 244
315 BASAL CELL CARCINOMA 243
316 GASTROENTERITIS VIRAL 243
317 CARDIAC FAILURE CONGESTIVE 239
318 CRYING 239
319 LABORATORY TEST ABNORMAL 239
320 TREATMENT NONCOMPLIANCE 239
321 HOT FLUSH 238
322 INTENTIONAL DOSE OMISSION 236
323 JOINT INJURY 235
324 BEHCET^S SYNDROME 234
325 LOCALISED INFECTION 233
326 RENAL DISORDER 232
327 HAEMORRHAGE 230
328 DISEASE RECURRENCE 226
329 PAIN OF SKIN 226
330 RASH VESICULAR 225
331 MUSCULOSKELETAL DISORDER 223
332 DYSPHONIA 222
333 FUNGAL INFECTION 220
334 CONGENITAL ANOMALY 219
335 DRY EYE 219
336 MYOSITIS 219
337 THERAPY PARTIAL RESPONDER 219
338 ULCER HAEMORRHAGE 219
339 LETHARGY 216
340 DERMATITIS 214
341 DRUG ERUPTION 214
342 SEIZURE 214
343 HYPOACUSIS 213
344 NEUROPATHY PERIPHERAL 213
345 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 213
346 BONE PAIN 209
347 POLLAKIURIA 209
348 VERTIGO 209
349 SPONDYLITIS 208
350 DYSPHAGIA 206
351 MULTIPLE ALLERGIES 206
352 BLOOD CREATININE INCREASED 205
353 ACNE 204
354 PORPHYRIA ACUTE 204
355 EPISTAXIS 202
356 FOETAL EXPOSURE DURING PREGNANCY 201
357 PANIC ATTACK 201
358 GENERAL SYMPTOM 198
359 THROMBOCYTOPENIA 198
360 POOR QUALITY SLEEP 196
361 NORMAL NEWBORN 192
362 THERAPEUTIC RESPONSE SHORTENED 191
363 CYSTITIS 188
364 SKIN PLAQUE 188
365 FEELING JITTERY 187
366 THROMBOSIS 186
367 ALANINE AMINOTRANSFERASE ABNORMAL 185
368 DRUG EFFECT LESS THAN EXPECTED 185
369 HYPERCALCAEMIA 185
370 EYE IRRITATION 183
371 RASH GENERALISED 182
372 GOUT 180
373 TINNITUS 179
374 SYNCOPE 178
375 LIMB INJURY 177
376 SEASONAL ALLERGY 176
377 BLOOD PRESSURE DECREASED 175
378 DRUG INTERACTION 175
379 MATERNAL EXPOSURE TIMING UNSPECIFIED 175
380 THERAPEUTIC RESPONSE UNEXPECTED 174
381 VIRAL INFECTION 173
382 ANGER 171
383 PANNICULITIS 171
384 RETCHING 171
385 RHEUMATOID NODULE 171
386 BLOOD PARATHYROID HORMONE DECREASED 168
387 LIMB DISCOMFORT 168
388 CARDIAC FAILURE 167
389 ORAL HERPES 167
390 SKIN NECROSIS 164
391 ABNORMAL DREAMS 162
392 EYE SWELLING 162
393 RESPIRATORY TRACT CONGESTION 162
394 STAPHYLOCOCCAL INFECTION 159
395 MENTAL DISORDER 158
396 LYMPHADENOPATHY 157
397 DRUG TOLERANCE 155
398 GALLBLADDER DISORDER 155
399 PRODUCT STORAGE ERROR 155
400 SKIN CANCER 155
401 BLOOD PRESSURE SYSTOLIC INCREASED 154
402 LUNG NEOPLASM MALIGNANT 154
403 NIGHTMARE 153
404 OXYGEN SATURATION DECREASED 153
405 APPLICATION SITE PRURITUS 152
406 UPPER LIMB FRACTURE 151
407 FOOT FRACTURE 150
408 IMMUNE SYSTEM DISORDER 150
409 AGITATION 149
410 OCULAR HYPERAEMIA 149
411 THROAT IRRITATION 149
412 GASTROINTESTINAL HAEMORRHAGE 146
413 NO THERAPEUTIC RESPONSE 145
414 BALANCE DISORDER 144
415 SNEEZING 144
416 WEIGHT FLUCTUATION 144
417 GRANULOMA SKIN 143
418 PROSTATE CANCER 143
419 SINUS HEADACHE 143
420 DYSPNOEA EXERTIONAL 142
421 PRODUCT PRESCRIBING ERROR 141
422 TOOTH DISORDER 140
423 FAECES DISCOLOURED 138
424 DEATH NEONATAL 137
425 EYE DISORDER 136
426 EYE PAIN 136
427 BOWEL MOVEMENT IRREGULARITY 135
428 IMPAIRED QUALITY OF LIFE 135
429 PHARYNGITIS STREPTOCOCCAL 135
430 DISEASE PROGRESSION 134
431 ERUCTATION 134
432 FLUSHING 134
433 IMMUNODEFICIENCY 134
434 SINUS CONGESTION 134
435 HEPATIC STEATOSIS 133
436 INFLAMMATORY BOWEL DISEASE 133
437 SPINAL FUSION SURGERY 133
438 KIDNEY INFECTION 132
439 NEURALGIA 132
440 DYSURIA 130
441 RED BLOOD CELL SEDIMENTATION RATE 130
442 EXPIRED PRODUCT ADMINISTERED 129
443 EYE PRURITUS 129
444 HALLUCINATION 129
445 FEAR OF INJECTION 128
446 INTERVERTEBRAL DISC PROTRUSION 128
447 FEEDING DISORDER 127
448 RESPIRATORY FAILURE 127
449 PAIN IN JAW 126
450 SCAB 126
451 DISTURBANCE IN ATTENTION 125
452 SPUTUM DISCOLOURED 124
453 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 122
454 LEUKOPENIA 121
455 SWOLLEN JOINT COUNT 121
456 ACCIDENTAL EXPOSURE TO PRODUCT 120
457 WHITE BLOOD CELL COUNT DECREASED 120
458 HAEMOGLOBIN DECREASED 119
459 IMPAIRED WORK ABILITY 119
460 CHRONIC KIDNEY DISEASE 118
461 EMPHYSEMA 117
462 OSTEOMYELITIS 117
463 HERNIA 116
464 INJECTION SITE ERYTHEMA 116
465 OVERLAP SYNDROME 116
466 PULMONARY EMBOLISM 116
467 SPINAL OPERATION 116
468 EMOTIONAL DISORDER 115
469 EMOTIONAL DISTRESS 115
470 DYSSTASIA 114
471 MOUTH ULCERATION 114
472 PULMONARY MASS 114
473 CONJUNCTIVITIS 113
474 HYPOCHOLESTEROLAEMIA 113
475 GRIP STRENGTH 112
476 PRODUCT DOSE OMISSION IN ERROR 112
477 SCRATCH 112
478 SENSITIVITY TO WEATHER CHANGE 112
479 GASTRITIS 111
480 HYPERSOMNIA 111
481 MUSCULOSKELETAL DISCOMFORT 110
482 ACUTE KIDNEY INJURY 109
483 FULL BLOOD COUNT ABNORMAL 109
484 RASH PAPULAR 109
485 GASTROINTESTINAL PAIN 107
486 HEAD DISCOMFORT 107
487 INCORRECT PRODUCT ADMINISTRATION DURATION 107
488 INJECTION SITE BRUISING 107
489 OBSTRUCTIVE AIRWAYS DISORDER 107
490 COLITIS 106
491 BLOOD GLUCOSE DECREASED 105
492 SECRETION DISCHARGE 105
493 TOOTH INFECTION 105
494 HAEMOPTYSIS 104
495 INJECTION SITE SWELLING 104
496 ANKLE FRACTURE 102
497 DEVICE MALFUNCTION 102
498 LYMPHOMA 102
499 MALIGNANT MELANOMA 102
500 ARRHYTHMIA 101
501 LACRIMATION INCREASED 101
502 PAPULE 101
503 TRANSIENT ISCHAEMIC ATTACK 101
504 ORAL PAIN 99
505 SKIN REACTION 98
506 WRIST FRACTURE 98
507 SKIN INFECTION 97
508 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 96
509 DEFAECATION URGENCY 96
510 DEVICE ISSUE 96
511 LIP SWELLING 96
512 PHOTOSENSITIVITY REACTION 96
513 SUICIDE ATTEMPT 96
514 ANGINA PECTORIS 95
515 DEEP VEIN THROMBOSIS 95
516 SARS-COV-2 TEST POSITIVE 95
517 ANGIOEDEMA 94
518 HIP FRACTURE 94
519 PRURITUS GENERALISED 94
520 MOVEMENT DISORDER 93
521 TUBERCULOSIS 93
522 ABDOMINAL PAIN LOWER 92
523 EATING DISORDER 92
524 MULTIPLE SCLEROSIS 92
525 MUSCLE SPASTICITY 92
526 TOOTHACHE 92
527 MIDDLE INSOMNIA 91
528 INSURANCE ISSUE 90
529 REBOUND PSORIASIS 90
530 BODY TEMPERATURE INCREASED 89
531 SKIN ATROPHY 89
532 DERMATITIS CONTACT 88
533 GLUCOSE TOLERANCE IMPAIRED 88
534 SPINAL DISORDER 88
535 ANAPHYLACTIC REACTION 87
536 BACTERIAL INFECTION 87
537 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 87
538 TOOTH ABSCESS 86
539 DACTYLITIS 85
540 GASTROINTESTINAL INFECTION 85
541 BLOOD TEST ABNORMAL 84
542 HYPERTRANSAMINASAEMIA 84
543 BLOOD PRESSURE ABNORMAL 83
544 COLD SWEAT 83
545 RIB FRACTURE 83
546 SPINAL FRACTURE 83
547 AFFECTIVE DISORDER 82
548 CHOLELITHIASIS 82
549 HEPATIC ENZYME 82
550 INTESTINAL OBSTRUCTION 82
551 QUALITY OF LIFE DECREASED 82
552 SPINAL PAIN 82
553 SWOLLEN TONGUE 82
554 BLINDNESS 81
555 BLOOD POTASSIUM DECREASED 81
556 CARPAL TUNNEL SYNDROME 81
557 IMMUNOSUPPRESSION 81
558 UVEITIS 81
559 ANKYLOSING SPONDYLITIS 80
560 APPLICATION SITE SWELLING 80
561 GASTRIC ULCER 80
562 PULMONARY CONGESTION 80
563 EAR DISCOMFORT 79
564 HAEMORRHOIDS 79
565 HYPOPHAGIA 79
566 RESTLESSNESS 79
567 THYROID DISORDER 79
568 COLON CANCER 78
569 MASS 78
570 ORAL CANDIDIASIS 78
571 EYELID IRRITATION 77
572 HEAD INJURY 77
573 HYPERLIPIDAEMIA 77
574 INJECTION SITE PRURITUS 77
575 SPEECH DISORDER 77
576 UPPER-AIRWAY COUGH SYNDROME 77
577 EXTRA DOSE ADMINISTERED 76
578 GRANULOMA 76
579 KNEE OPERATION 76
580 POLYARTHRITIS 76
581 AGEUSIA 75
582 CANDIDA INFECTION 75
583 MUSCULOSKELETAL CHEST PAIN 75
584 CYST 74
585 PULMONARY OEDEMA 74
586 THINKING ABNORMAL 74
587 BONE DENSITY DECREASED 73
588 EYE INFECTION 73
589 HEART RATE IRREGULAR 73
590 HYPOKALAEMIA 73
591 ABORTION SPONTANEOUS 72
592 BONE DISORDER 72
593 CLOSTRIDIUM DIFFICILE INFECTION 72
594 DEMENTIA 72
595 HEART RATE DECREASED 72
596 MUSCLE STRAIN 72
597 HAEMATEMESIS 71
598 PHOTOPHOBIA 71
599 PURPURA 71
600 BLOOD URINE PRESENT 70
601 DISORIENTATION 70
602 ONYCHOCLASIS 70
603 BLADDER CANCER 69
604 DERMATITIS ALLERGIC 69
605 HYPOTHYROIDISM 69
606 INJECTION SITE HAEMORRHAGE 69
607 PLATELET COUNT DECREASED 69
608 ACCIDENTAL OVERDOSE 68
609 INFECTION SUSCEPTIBILITY INCREASED 68
610 PIGMENTATION DISORDER 68
611 SKIN LACERATION 68
612 ADRENAL INSUFFICIENCY 67
613 BRONCHOSPASM 67
614 DEAFNESS 67
615 PRODUCT DISPENSING ERROR 67
616 SLEEP APNOEA SYNDROME 67
617 CONCUSSION 66
618 EYE INJURY 66
619 VIRAL UPPER RESPIRATORY TRACT INFECTION 66
620 ACUTE RESPIRATORY FAILURE 65
621 PNEUMONITIS 65
622 APPLICATION SITE BURN 64
623 CHROMATURIA 64
624 INTERVERTEBRAL DISC DEGENERATION 64
625 JOINT EFFUSION 64
626 PLEURAL EFFUSION 64
627 SKIN INJURY 64
628 SQUAMOUS CELL CARCINOMA OF SKIN 64
629 TENDERNESS 64
630 INTERSTITIAL LUNG DISEASE 63
631 ARTHROPOD BITE 62
632 MACULE 62
633 ACCIDENT 61
634 LUNG INFECTION 61
635 ROTATOR CUFF SYNDROME 61
636 BLOOD PRESSURE FLUCTUATION 60
637 CARDIAC OPERATION 60
638 DEPRESSION SUICIDAL 60
639 FEELING COLD 60
640 GLAUCOMA 60
641 PNEUMOTHORAX 60
642 SQUAMOUS CELL CARCINOMA 60
643 VAGINAL HAEMORRHAGE 60
644 APHONIA 59
645 APPLICATION SITE IRRITATION 59
646 BODY TINEA 59
647 COVID-19 PNEUMONIA 59
648 FURUNCLE 59
649 LICHEN PLANUS 59
650 MUSCLE TIGHTNESS 59
651 NODULE 59
652 PALMOPLANTAR PUSTULOSIS 59
653 THROAT TIGHTNESS 59
654 BRONCHIECTASIS 58
655 RESTLESS LEGS SYNDROME 58
656 EPIGASTRIC DISCOMFORT 57
657 FACIAL PAIN 57
658 GLYCOSYLATED HAEMOGLOBIN INCREASED 57
659 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 57
660 ORAL DISORDER 57
661 RENAL PAIN 57
662 SENSORY DISTURBANCE 57
663 TENDON RUPTURE 57
664 THERAPY CHANGE 57
665 ANAPHYLACTIC SHOCK 56
666 DECREASED IMMUNE RESPONSIVENESS 56
667 HEPATIC FIBROSIS 56
668 INHIBITORY DRUG INTERACTION 56
669 BLOOD IRON DECREASED 55
670 HYPOGLYCAEMIA 55
671 INCREASED APPETITE 55
672 INITIAL INSOMNIA 55
673 RESPIRATION ABNORMAL 55
674 BREAST CANCER STAGE I 54
675 CARDIAC ARREST 54
676 FEMUR FRACTURE 54
677 INCREASED TENDENCY TO BRUISE 54
678 NERVE COMPRESSION 54
679 PARANASAL SINUS DISCOMFORT 54
680 SEPTIC SHOCK 54
681 THIRST 54
682 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 54
683 AGGRESSION 53
684 DRY THROAT 53
685 FOOD POISONING 53
686 DEPRESSIVE SYMPTOM 52
687 FRACTURE 52
688 HAEMATURIA 52
689 HEPATITIS C 52
690 HYPOXIA 52
691 MENISCUS INJURY 52
692 OSTEOPENIA 52
693 URINARY RETENTION 52
694 ABNORMAL FAECES 51
695 BODY HEIGHT DECREASED 51
696 CHOLECYSTECTOMY 51
697 DECREASED INTEREST 51
698 DIARRHOEA HAEMORRHAGIC 51
699 EXPOSURE VIA SKIN CONTACT 51
700 SKIN HYPERPIGMENTATION 51
701 SLUGGISHNESS 51
702 TENDON PAIN 51
703 APPLICATION SITE RASH 50
704 BLOOD GLUCOSE ABNORMAL 50
705 JOINT DESTRUCTION 50
706 LATENT TUBERCULOSIS 50
707 MENORRHAGIA 50
708 SUSPECTED OFF LABEL USE 50
709 BIPOLAR DISORDER 49
710 LIGAMENT SPRAIN 49
711 MUCOSAL INFLAMMATION 49
712 THERAPEUTIC PRODUCT EFFECT DELAYED 49
713 ASPIRATION 48
714 DRUG ADMINISTRATION ERROR 48
715 INJECTION SITE MASS 48
716 PRESYNCOPE 48
717 ABSCESS 47
718 APATHY 47
719 COGNITIVE DISORDER 47
720 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 47
721 MENSTRUAL DISORDER 47
722 NERVOUS SYSTEM DISORDER 47
723 PRODUCT DISTRIBUTION ISSUE 47
724 RHEUMATOID LUNG 47
725 ROSACEA 47
726 SYMPTOM RECURRENCE 47
727 TOXICITY TO VARIOUS AGENTS 47
728 INFLAMMATORY MARKER INCREASED 46
729 PARKINSON^S DISEASE 46
730 PAROSMIA 46
731 RASH PUSTULAR 46
732 SKIN SWELLING 46
733 CORONARY ARTERY DISEASE 45
734 DIPLOPIA 45
735 HYPOAESTHESIA ORAL 45
736 INJECTION SITE RASH 45
737 PRODUCT PRESCRIBING ISSUE 45
738 RESPIRATORY DISTRESS 45
739 SCAR 45
740 SHOULDER OPERATION 45
741 SPINAL OSTEOARTHRITIS 45
742 STREPTOCOCCAL INFECTION 45
743 VITAMIN D DEFICIENCY 45
744 EYE DISCHARGE 44
745 HYPERTHYROIDISM 44
746 ORAL DISCOMFORT 44
747 POOR VENOUS ACCESS 44
748 APPETITE DISORDER 43
749 BRAIN FOG 43
750 BRAIN NEOPLASM 43
751 COMPLETED SUICIDE 43
752 FRUSTRATION TOLERANCE DECREASED 43
753 INTESTINAL HAEMORRHAGE 43
754 MULTIPLE SCLEROSIS RELAPSE 43
755 POOR QUALITY PRODUCT ADMINISTERED 43
756 SUNBURN 43
757 TENDON DISORDER 43
758 BLADDER DISORDER 42
759 BREATH SOUNDS ABNORMAL 42
760 CORONAVIRUS INFECTION 42
761 FACE OEDEMA 42
762 FOOT OPERATION 42
763 LIVER FUNCTION TEST ABNORMAL 42
764 PEMPHIGOID 42
765 PHARYNGEAL OEDEMA 42
766 PROCEDURAL PAIN 42
767 BEDRIDDEN 41
768 CEREBRAL HAEMORRHAGE 41
769 GASTROINTESTINAL SOUNDS ABNORMAL 41
770 HIDRADENITIS 41
771 INJECTION SITE URTICARIA 41
772 MICTURITION URGENCY 41
773 NEPHROPATHY 41
774 PHARYNGITIS 41
775 SKIN DISCOMFORT 41
776 SKIN PAPILLOMA 41
777 THERMAL BURN 41
778 ABNORMAL BEHAVIOUR 40
779 BLOOD TRIGLYCERIDES INCREASED 40
780 CHEILITIS 40
781 GASTROENTERITIS 40
782 LEUKAEMIA 40
783 MENSTRUATION IRREGULAR 40
784 POLYP 40
785 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 40
786 RED CELL DISTRIBUTION WIDTH INCREASED 40
787 ABASIA 39
788 APPLICATION SITE DISCOLOURATION 39
789 CONCOMITANT DISEASE AGGRAVATED 39
790 FULL BLOOD COUNT DECREASED 39
791 HEPATIC FUNCTION ABNORMAL 39
792 POST PROCEDURAL COMPLICATION 39
793 STENT PLACEMENT 39
794 TEMPERATURE INTOLERANCE 39
795 WITHDRAWAL SYNDROME 39
796 ACUTE MYOCARDIAL INFARCTION 38
797 ARTHRITIS INFECTIVE 38
798 MAJOR DEPRESSION 38
799 MELANOCYTIC NAEVUS 38
800 MUSCLE TWITCHING 38
801 PANCYTOPENIA 38
802 PARAESTHESIA ORAL 38
803 PRODUCT ADMINISTRATION ERROR 38
804 RHINITIS 38
805 SPINAL CORD COMPRESSION 38
806 TRANSAMINASES INCREASED 38
807 APPENDICITIS 37
808 BREAST PAIN 37
809 GENERALISED ERYTHEMA 37
810 HIATUS HERNIA 37
811 HYSTERECTOMY 37
812 PANCREATIC CARCINOMA 37
813 PARANOIA 37
814 PELVIC FRACTURE 37
815 POST PROCEDURAL INFECTION 37
816 RENAL CANCER 37
817 SKIN MASS 37
818 SWELLING OF EYELID 37
819 URINE ODOUR ABNORMAL 37
820 CHOKING 36
821 DANDRUFF 36
822 FLANK PAIN 36
823 JOINT ANKYLOSIS 36
824 MENTAL STATUS CHANGES 36
825 NERVE INJURY 36
826 OCULAR DISCOMFORT 36
827 OVERWEIGHT 36
828 PNEUMONIA BACTERIAL 36
829 PSYCHOTIC DISORDER 36
830 CUTANEOUS T-CELL LYMPHOMA 35
831 ENERGY INCREASED 35
832 FACIAL PARALYSIS 35
833 HIP SURGERY 35
834 HYPERGLYCAEMIA 35
835 IMPAIRED GASTRIC EMPTYING 35
836 LACERATION 35
837 MACULAR DEGENERATION 35
838 OSTEOLYSIS 35
839 PRODUCT PHYSICAL ISSUE 35
840 PYELONEPHRITIS 35
841 SACROILIITIS 35
842 SINUS PAIN 35
843 BLOOD POTASSIUM INCREASED 34
844 BLOOD SODIUM DECREASED 34
845 BONE CYST 34
846 BREAST CANCER FEMALE 34
847 CLOSTRIDIUM DIFFICILE COLITIS 34
848 COMA 34
849 EYE HAEMORRHAGE 34
850 INTERNAL HAEMORRHAGE 34
851 MENTAL IMPAIRMENT 34
852 MUSCLE ATROPHY 34
853 PULMONARY THROMBOSIS 34
854 RALES 34
855 RESPIRATORY SYMPTOM 34
856 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34
857 SENSITIVE SKIN 34
858 SPUTUM INCREASED 34
859 UPPER RESPIRATORY TRACT CONGESTION 34
860 URINARY INCONTINENCE 34
861 VARICOSE VEIN 34
862 VITAMIN D DECREASED 34
863 ACTIVITIES OF DAILY LIVING IMPAIRED 33
864 BRONCHIAL SECRETION RETENTION 33
865 DEMENTIA ALZHEIMER^S TYPE 33
866 DRUG PRESCRIBING ERROR 33
867 GASTROINTESTINAL INFLAMMATION 33
868 HYPERAESTHESIA 33
869 MYASTHENIA GRAVIS 33
870 PALLOR 33
871 PRODUCT COLOUR ISSUE 33
872 PRODUCT PHYSICAL CONSISTENCY ISSUE 33
873 PRODUCT USE COMPLAINT 33
874 RED BLOOD CELL COUNT DECREASED 33
875 RETINAL DETACHMENT 33
876 SEBORRHOEIC KERATOSIS 33
877 SKIN ABRASION 33
878 SKIN WEEPING 33
879 SYNOVIAL CYST 33
880 UTERINE CANCER 33
881 VASCULITIS 33
882 EOSINOPHILIA 32
883 FOOD ALLERGY 32
884 HAND FRACTURE 32
885 HEPATIC CANCER 32
886 INCORRECT DOSAGE ADMINISTERED 32
887 INTRACRANIAL ANEURYSM 32
888 PSYCHIATRIC SYMPTOM 32
889 SJOGREN^S SYNDROME 32
890 TOOTH FRACTURE 32
891 APHTHOUS ULCER 31
892 APPLICATION SITE INFLAMMATION 31
893 ARTHRITIS BACTERIAL 31
894 CARDIOVASCULAR DISORDER 31
895 HEPATIC FAILURE 31
896 MUSCLE DISORDER 31
897 THYROID CANCER 31
898 ANAL INCONTINENCE 30
899 BRONCHIAL WALL THICKENING 30
900 CARDIAC VALVE DISEASE 30
901 FUNCTIONAL GASTROINTESTINAL DISORDER 30
902 GROIN PAIN 30
903 HORDEOLUM 30
904 INABILITY TO AFFORD MEDICATION 30
905 IRON DEFICIENCY ANAEMIA 30
906 JOINT LOCK 30
907 LIMB OPERATION 30
908 LOW DENSITY LIPOPROTEIN INCREASED 30
909 LYME DISEASE 30
910 OROPHARYNGEAL DISCOMFORT 30
911 OVARIAN CANCER 30
912 PHARYNGEAL SWELLING 30
913 SEBORRHOEA 30
914 SENSATION OF FOREIGN BODY 30
915 SKIN EROSION 30
916 SKIN HYPERTROPHY 30
917 APPLICATION SITE VESICLES 29
918 BACTERIAL DISEASE CARRIER 29
919 BLINDNESS UNILATERAL 29
920 COLONOSCOPY 29
921 DRUG RESISTANCE 29
922 DYSARTHRIA 29
923 ERECTILE DYSFUNCTION 29
924 ESSENTIAL HYPERTENSION 29
925 GASTRIC INFECTION 29
926 HYPERKERATOSIS 29
927 LIGAMENT RUPTURE 29
928 LYMPHOEDEMA 29
929 MELAENA 29
930 NASAL DISCOMFORT 29
931 NEGATIVE THOUGHTS 29
932 NEOPLASM 29
933 NEUTROPENIA 29
934 PERICARDIAL EFFUSION 29
935 POLYMYALGIA RHEUMATICA 29
936 PRODUCT AVAILABILITY ISSUE 29
937 PSYCHOMOTOR HYPERACTIVITY 29
938 RAYNAUD^S PHENOMENON 29
939 UTERINE DISORDER 29
940 BLOOD GLUCOSE FLUCTUATION 28
941 CEREBRAL DISORDER 28
942 EAR DISORDER 28
943 FEAR 28
944 NEURODERMATITIS 28
945 REBOUND EFFECT 28
946 RHINITIS ALLERGIC 28
947 SALIVARY HYPERSECRETION 28
948 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28
949 ABNORMAL LOSS OF WEIGHT 27
950 ARTERIOSCLEROSIS 27
951 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 27
952 COLITIS MICROSCOPIC 27
953 DEAFNESS UNILATERAL 27
954 EXFOLIATIVE RASH 27
955 HAEMATOMA 27
956 HEART RATE ABNORMAL 27
957 HYPONATRAEMIA 27
958 INCORRECT DOSE ADMINISTERED BY DEVICE 27
959 INTRAOCULAR PRESSURE INCREASED 27
960 JOINT ARTHROPLASTY 27
961 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27
962 PANCREATITIS ACUTE 27
963 PARANASAL SINUS HYPERSECRETION 27
964 PERIPHERAL COLDNESS 27
965 REHABILITATION THERAPY 27
966 TOOTH EXTRACTION 27
967 APHASIA 26
968 ARTERIAL OCCLUSIVE DISEASE 26
969 AUTOIMMUNE HEPATITIS 26
970 B-CELL LYMPHOMA 26
971 BACTERAEMIA 26
972 BREAST TENDERNESS 26
973 CARDIAC FLUTTER 26
974 CORONARY ARTERY OCCLUSION 26
975 DERMATITIS EXFOLIATIVE GENERALISED 26
976 EAR CONGESTION 26
977 EOSINOPHIL COUNT INCREASED 26
978 FEELING OF BODY TEMPERATURE CHANGE 26
979 GENERALISED OEDEMA 26
980 HEPATOMEGALY 26
981 HUNGER 26
982 HYPOKINESIA 26
983 INFECTIOUS MONONUCLEOSIS 26
984 INFUSION SITE PAIN 26
985 MIDDLE EAR EFFUSION 26
986 NONSPECIFIC REACTION 26
987 OESOPHAGEAL CARCINOMA 26
988 PLEURISY 26
989 POSTOPERATIVE WOUND INFECTION 26
990 SENSORY LOSS 26
991 SUPRAVENTRICULAR TACHYCARDIA 26
992 ACTINIC KERATOSIS 25
993 ANOSMIA 25
994 APPLICATION SITE PARAESTHESIA 25
995 APPLICATION SITE URTICARIA 25
996 BLOOD COUNT ABNORMAL 25
997 BODY TEMPERATURE DECREASED 25
998 CARDIAC PACEMAKER INSERTION 25
999 COMPRESSION FRACTURE 25